Bruker (BRKR)

Company Profile

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with its customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

Company profile

Ticker

BRKR

Exchange

NASDAQ

Website

www.bruker.com

CEO

Frank Laukien

Incorporated

Delaware

Location

Massachusetts

Fiscal year end

Dec 31

Sector

Manufacturing > Analytical Laboratory Instrument Manufacturing

Industry (SIC)

Laboratory Analytical Instruments

Agilent • Bio-Rad Laboratories • Waters • Illumina • Avantor • Mettler-Toledo International • Perkinelmer • Seer • Cue Health • Cytek BioSciences ...

Former names

BRUKER BIOSCIENCES CORP, BRUKER DALTONICS INC

SEC CIK

0001109354

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Acuity Spatial Genomics, Inc. • Advanced Diagnostic Solutions (Pty) Ltd. • Agapetus GmbH • Alicona Imaging GmbH • Anasys Instruments Corporation • Bruker Arabia Limited • Bruker AXS Holdings, Inc. • Bruker AXS LLC • Bruker AXS Ltd. • Bruker AXS GmbH ...

IRS number

43110160

BRKR stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

8-K

Results of Operations and Financial Condition

4 Nov 22

Bruker Reports Third Quarter 2022 Financial Results

5 Aug 22

Bruker Reports Second Quarter 2022 Financial Results

3 Aug 22

S-8

Registration of securities for employees

3 Jun 22

8-K

Submission of Matters to a Vote of Security Holders

1 Jun 22

Conflict minerals disclosure

6 May 22

Bruker Reports First Quarter Financial Results

4 May 22

Transcripts

View all

BRKR

Earnings call transcript

2022 Q2

4 Aug 22

BRKR

Earnings call transcript

2022 Q1

4 May 22

BRKR

Earnings call transcript

2021 Q4

11 Feb 22

BRKR

Earnings call transcript

2021 Q3

2 Nov 21

BRKR

Earnings call transcript

2021 Q2

3 Aug 21

BRKR

Earnings call transcript

2021 Q1

8 May 21

BRKR

Earnings call transcript

2020 Q4

16 Feb 21

BRKR

Earnings call transcript

2020 Q3

3 Nov 20

BRKR

Earnings call transcript

2020 Q3

3 Nov 20

BRKR

Earnings call transcript

2020 Q3

3 Nov 20

Latest ownership filings

View all

Hermann Fritz Requardt

9 Jan 23

Financial summary

Financial statements Chart BRKR financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	629.30 mm	629.30 mm	629.30 mm	629.30 mm	629.30 mm	629.30 mm
Cash burn (monthly)	32.33 mm	(no burn)	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	128.11 mm	n/a	n/a	n/a	n/a	n/a
Cash remaining	501.19 mm	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	15.5	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from Bruker earnings reports.

Institutional ownership, Q3 2022

BRKR institutional ownership history Ownership history

68.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	274	288	-4.9%
Opened positions	34	34	–
Closed positions	48	55	-12.7%
Increased positions	84	89	-5.6%
Reduced positions	115	119	-3.4%

13F shares	Current	Prev Q	Change
Total value	5.36 bn	6.45 bn	-16.9%
Total shares	100.41 mm	102.52 mm	-2.1%
Total puts	14.10 k	33.30 k	-57.7%
Total calls	99.80 k	53.40 k	+86.9%
Total put/call ratio	0.1	0.6	-77.3%

Largest owners	Shares	Value	Change
T. Rowe Price Investment Management	16.40 mm	$870.18 mm	NEW
FMR	12.16 mm	$645.11 mm	-2.2%
BLK Blackrock	10.99 mm	$583.27 mm	+0.5%
Vanguard	10.95 mm	$581.07 mm	-1.5%
Massachusetts Financial Services	7.23 mm	$383.77 mm	+16.9%
Alliancebernstein	3.23 mm	$171.25 mm	-14.4%
T. Rowe Price	3.11 mm	$164.91 mm	-84.0%
Fuller & Thaler Asset Management	1.95 mm	$103.38 mm	-0.6%
Pallas Capital Advisors	1.74 mm	$92.27 mm	0.0%
Geode Capital Management	1.67 mm	$88.74 mm	+2.3%

Largest transactions	Shares	Bought/sold	Change
T. Rowe Price Investment Management	16.40 mm	+16.40 mm	NEW
T. Rowe Price	3.11 mm	-16.37 mm	-84.0%
STT State Street	0.00	-3.08 mm	EXIT
Millennium Management	1.44 mm	+1.24 mm	+630.0%
Massachusetts Financial Services	7.23 mm	+1.04 mm	+16.9%
GS Goldman Sachs	422.53 k	-631.15 k	-59.9%
Fred Alger Management	1.01 mm	+611.00 k	+151.8%
Alliancebernstein	3.23 mm	-544.27 k	-14.4%
AMP Ameriprise Financial	660.50 k	+506.85 k	+329.9%
Farallon Capital Management	943.80 k	-463.00 k	-32.9%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

BRKR insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
17 Jan 23	Friend Cynthia M	Common Stock	Sell	Dispose S	No	Yes	68.26	921	62.87 k	11,576
5 Jan 23	Adelene Q Perkins	Common Stock	Grant	Acquire A	No	No	0	1,970	0.00	18,949
5 Jan 23	Hermann Fritz Requardt	Common Stock	Grant	Acquire A	No	No	0	1,970	0.00	20,770
5 Jan 23	Friend Cynthia M	Common Stock	Grant	Acquire A	No	No	0	1,970	0.00	12,497
5 Jan 23	Marc A Kastner	Common Stock	Grant	Acquire A	No	No	0	1,970	0.00	20,021